These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 23080479)

  • 1. Maternal use of SSRIs, SNRIs and NaSSAs: practical recommendations during pregnancy and lactation.
    Sie SD; Wennink JM; van Driel JJ; te Winkel AG; Boer K; Casteelen G; van Weissenbruch MM
    Arch Dis Child Fetal Neonatal Ed; 2012 Nov; 97(6):F472-6. PubMed ID: 23080479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
    Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
    Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SSRI use during pregnancy.
    Tran H; Robb AS
    Semin Perinatol; 2015 Nov; 39(7):545-7. PubMed ID: 26428019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective serotonin reuptake inhibitors in pregnancy.
    Bellissima V; Ververs TF; Visser GH; Gazzolo D
    Curr Med Chem; 2012; 19(27):4554-61. PubMed ID: 22876893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of antidepressant use in pregnant and nursing women.
    Lamberg L
    JAMA; 1999 Jul; 282(3):222-3. PubMed ID: 10422977
    [No Abstract]   [Full Text] [Related]  

  • 6. Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative data.
    Singal D; Brownell M; Chateau D; Ruth C; Katz LY
    BMJ Open; 2016 Nov; 6(11):e013293. PubMed ID: 27899401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring.
    Brown AS; Gyllenberg D; Malm H; McKeague IW; Hinkka-Yli-Salomäki S; Artama M; Gissler M; Cheslack-Postava K; Weissman MM; Gingrich JA; Sourander A
    JAMA Psychiatry; 2016 Nov; 73(11):1163-1170. PubMed ID: 27732704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of SSRIs during pregnancy and possible consequences for the development of the child].
    van der Veere CN; Bos AF
    Ned Tijdschr Geneeskd; 2007 Dec; 151(52):2873-4. PubMed ID: 18257430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.
    Oberlander TF; Misri S; Fitzgerald CE; Kostaras X; Rurak D; Riggs W
    J Clin Psychiatry; 2004 Feb; 65(2):230-7. PubMed ID: 15003078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes.
    El Marroun H; Jaddoe VW; Hudziak JJ; Roza SJ; Steegers EA; Hofman A; Verhulst FC; White TJ; Stricker BH; Tiemeier H
    Arch Gen Psychiatry; 2012 Jul; 69(7):706-14. PubMed ID: 22393202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [TREATMENT OF SEROTONIN AND NOREPINEPHRINE REUPTAKE INHIBITORS (SSRIS AND SNRIS) DURING PREGNANCY AND LACTATION].
    Rozner L; Aisenberg Romano G; Klieger C; Bloch M
    Harefuah; 2023 Feb; 162(2):86-91. PubMed ID: 36916077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of newer antidepressants in pregnancy.
    Way CM
    Pharmacotherapy; 2007 Apr; 27(4):546-52. PubMed ID: 17381382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The safety profile of escitalopram in pregnancy and breastfeeding].
    Bellantuono C; Orsolini L; Bozzi F
    Riv Psichiatr; 2013; 48(6):407-14. PubMed ID: 24441517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
    Nulman I; Koren G; Rovet J; Barrera M; Pulver A; Streiner D; Feldman B
    Am J Psychiatry; 2012 Nov; 169(11):1165-74. PubMed ID: 23128923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antenatal depression and antidepressants during pregnancy: unraveling the complex interactions for the offspring.
    Olivier JD; Åkerud H; Sundström Poromaa I
    Eur J Pharmacol; 2015 Apr; 753():257-62. PubMed ID: 25094036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal SSRI exposure: Effects on later child development.
    Hermansen TK; Melinder A
    Child Neuropsychol; 2015; 21(5):543-69. PubMed ID: 25089614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn.
    Chambers CD; Hernandez-Diaz S; Van Marter LJ; Werler MM; Louik C; Jones KL; Mitchell AA
    N Engl J Med; 2006 Feb; 354(6):579-87. PubMed ID: 16467545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal SSRI exposure increases the risk of autistic offspring: A meta-analysis and systematic review.
    Andalib S; Emamhadi MR; Yousefzadeh-Chabok S; Shakouri SK; Høilund-Carlsen PF; Vafaee MS; Michel TM
    Eur Psychiatry; 2017 Sep; 45():161-166. PubMed ID: 28917161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early morbidity and mortality following in utero exposure to selective serotonin reuptake inhibitors: a population-based study in Western Australia.
    Colvin L; Slack-Smith L; Stanley FJ; Bower C
    CNS Drugs; 2012 Jul; 26(7):e1-14. PubMed ID: 22712699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [SSRIs and pregnancy: a review of the literature].
    Soufia M; Aoun J; Gorsane MA; Krebs MO
    Encephale; 2010 Dec; 36(6):513-6. PubMed ID: 21130237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.